FOSTER CITY, Calif.--(BUSINESS WIRE)--April 20, 2006--Gilead Sciences, Inc. (Nasdaq:GILD - News) today announced the pricing of $600 million principal amount of Convertible Senior Notes due 2011 and $600 million principal amount of Convertible Senior Notes due 2013, for an aggregate transaction size of $1.2 billion. This represents an increase of $100 million from the aggregate transaction size announced April 18, 2006. Gilead granted the initial purchasers an option to purchase an additional $50 million of the 2011 notes and $50 million of the 2013 notes to cover overallotments. The notes are being sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
